SMART Prices Act
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To amend title XVIII of the Social Security Act to strengthen the drug
pricing reforms in the Inflation Reduction Act., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Immigration, Social Welfare.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section S1: 1. Short title This Act may be cited as the Strengthening Medicare And Reducing Taxpayer Prices Act or the SMART Prices Act.
- Section idf6b3133447fb4e7187bfa02dc61187c5: 2. Improvements to the Medicare Drug Price Negotiation Program Section 1192(a) of the Social Security Act (42 U.S.C. 1320f–1(a)) is amended— in paragraph (3)—...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To amend title XVIII of the Social Security Act to strengthen the drug pricing reforms in the Inflation Reduction Act., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Immigration, Social Welfare
Primary Purpose
This bill, To amend title XVIII of the Social Security Act to strengthen the drug pricing reforms in the Inflation Reduction Act., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
In CommitteeMs. Klobuchar (for herself, Mr. Welch, Ms. Smith, Mr. King, …
Read twice and referred to the Committee on Finance.
Introduced in Senate
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "federal_implementing_agencies"
- → Federal agencies assigned duties by the bill
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology